<?xml version="1.0" encoding="UTF-8"?>
<eudamedExport entity="devices">
  <row>
    <udiDi>++G287HUMA138YU</udiDi>
    <basicUdiDi>++G287HUMAII7R</basicUdiDi>
    <tradeName>++G287HUMA138YU</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Huma Therapeutics Limited</manufacturerName>
    <manufacturerSrn>GB-MF-000031420</manufacturerSrn>
    <authorisedRepresentativeName>Advena Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>MT-AR-000000234</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription></emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>HUMA THERAPEUTICS</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-19T19:49:39.098Z</lastUpdated>
  </row>
  <row>
    <udiDi>*+G28701/$$71.24T*</udiDi>
    <basicUdiDi>++G287HUMAII7R</basicUdiDi>
    <tradeName>*+G28701/$$71.24T*</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Huma Therapeutics Limited</manufacturerName>
    <manufacturerSrn>GB-MF-000031420</manufacturerSrn>
    <authorisedRepresentativeName>Advena Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>MT-AR-000000234</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription></emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference></reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-05T18:32:37.699Z</lastUpdated>
  </row>
</eudamedExport>